Table 1.
Means of systemic antibiotic use in the two main periods.
| Pre-COVID Period | COVID-19 Period | |||
|---|---|---|---|---|
| DID 1 | % | DID 1 | % | |
| J01A Tetracyclines | 0.77 | 6.34 | 0.78 | 8.35 |
| J01CA Penicillins with extended spectrum | 0.61 | 5.04 | 0.29 | 3.12 |
| J01CE Beta-lactamase sensitive penicillins | 0.17 | 1.41 | 0.06 | 0.65 |
| J01CR Combinations of penicillins, incl. beta-lactamase inhibitors | 3.37 | 27.85 | 2.71 | 29.17 |
| J01C Beta-lactam antibacterials, penicillins | 4.15 | 34.28 | 3.06 | 32.91 |
| J01DC Second-generation cephalosporins | 1.70 | 14.05 | 1.08 | 11.62 |
| J01DD Third-generations cephalosporins | 0.27 | 2.23 | 0.24 | 2.58 |
| J01D Cephalosporins | 1.97 | 16.25 | 1.32 | 14.24 |
| J01E Sulfonamides and trimethoprim | 0.43 | 3.57 | 0.36 | 3.88 |
| J01FA Macrolides | 2.00 | 16.53 | 1.89 | 20.34 |
| J01FF Lincosamides | 0.50 | 4.13 | 0.47 | 5.06 |
| J01F Macrolides, lincosamides | 2.49 | 20.59 | 2.35 | 25.34 |
| J01M Quinolone antibacterials | 2.22 | 18.35 | 1.41 | 15.15 |
| J01X Other antibacterials | 0.06 | 0.53 | 0.01 | 0.07 |
| J01 Antibacterials | 12.10 | 100.00 | 9.29 | 100.00 |
1 DID: DDD per 1000 inhabitants per day.